Literature DB >> 19470387

Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl/6J mice.

Robert E Vann1, Jonathan A Warner, Kristen Bushell, John W Huffman, Billy R Martin, Jenny L Wiley.   

Abstract

Primarily, rats have served as subjects in Delta(9)-tetrahydrocannabinol's (THC) discrimination studies although other species such as monkeys and pigeons have been used. While the introduction of the knockout and transgenic mice has vastly stimulated the study of the discriminative stimulus effects of drugs there is only a single published report of mice trained to discriminate THC. Thus, this study extended those results by providing a systematic replication that THC serves as an effective discriminative stimulus in mice and by further investigating the mechanisms of action involved in the THC discrimination model in the mouse. Male C57BL/6J mice were trained to discriminate 10 mg/kg THC from vehicle in 2-lever drug discrimination. THC fully and dose dependently substituted for itself. Cannabinoid indoles, except one with low cannabinoid CB(1) receptor affinity, substituted for THC. Anandamide failed to substitute for THC when administered alone but completely substituted when administered with the non-specific fatty acid amide hydrolase inhibitor, phenylmethylsulphonyl fluoride. As expected, nicotine failed to substitute for THC. Lastly, the cannabinoid CB(1) receptor antagonist rimonabant blocked THC's discriminative stimulus effects. Taken together these studies demonstrate THC's ability to produce discriminative stimulus effects as well as demonstrate its pharmacological specificity and mechanism of action in a two-lever drug discrimination mouse model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19470387      PMCID: PMC2740481          DOI: 10.1016/j.ejphar.2009.05.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  48 in total

1.  Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs.

Authors:  B R Martin; D R Compton; B F Thomas; W R Prescott; P J Little; R K Razdan; M R Johnson; L S Melvin; R Mechoulam; S J Ward
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

2.  Delta9-tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus)

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Pharmacol Biochem Behav       Date:  1975 May-Jun       Impact factor: 3.533

3.  delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111.

Authors:  T U Järbe; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization.

Authors:  F Desarnaud; H Cadas; D Piomelli
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

5.  Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Authors:  D R Compton; K C Rice; B R De Costa; R K Razdan; L S Melvin; M R Johnson; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1993-04       Impact factor: 4.030

6.  Pentobarbital discrimination in the mouse.

Authors:  R L Balster; V C Moser
Journal:  Alcohol Drug Res       Date:  1987

7.  A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

Authors:  Jenny L Wiley; Kari L LaVecchia; Natalie E Karp; Sanjitha Kulasegram; Anu Mahadevan; Raj K Razdan; Billy R Martin
Journal:  Exp Clin Psychopharmacol       Date:  2004-08       Impact factor: 3.157

Review 8.  Delta 9-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication.

Authors:  R L Balster; W R Prescott
Journal:  Neurosci Biobehav Rev       Date:  1992       Impact factor: 8.989

9.  Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.

Authors:  I B Adams; W Ryan; M Singer; B F Thomas; D R Compton; R K Razdan; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1995-06       Impact factor: 4.030

10.  Discriminative stimulus and subjective effects of smoked marijuana in humans.

Authors:  L D Chait; S M Evans; K A Grant; J B Kamien; C E Johanson; C R Schuster
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  30 in total

Review 1.  Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Authors:  Kathryn A Seely; Jeff Lapoint; Jeffery H Moran; Liana Fattore
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-26       Impact factor: 5.067

2.  Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.

Authors:  Jenny L Wiley; Julie A Marusich; Timothy W Lefever; Megan Grabenauer; Katherine N Moore; Brian F Thomas
Journal:  Neuropharmacology       Date:  2013-08-02       Impact factor: 5.250

3.  Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Authors:  Jenny L Wiley; D Matthew Walentiny; M Jerry Wright; Patrick M Beardsley; James J Burston; Justin L Poklis; Aron H Lichtman; Robert E Vann
Journal:  Eur J Pharmacol       Date:  2014-05-22       Impact factor: 4.432

Review 4.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

5.  Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.

Authors:  Jenny L Wiley; D Matthew Walentiny; Robert E Vann; Cassandra Y Baskfield
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 6.  Baths salts, spice, and related designer drugs: the science behind the headlines.

Authors:  Michael H Baumann; Ernesto Solis; Lucas R Watterson; Julie A Marusich; William E Fantegrossi; Jenny L Wiley
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

7.  Differential drug-drug interactions of the synthetic Cannabinoids JWH-018 and JWH-073: implications for drug abuse liability and pain therapy.

Authors:  Lisa K Brents; Sarah M Zimmerman; Amanda R Saffell; Paul L Prather; William E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2013-06-25       Impact factor: 4.030

8.  Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Timothy W Lefever; Julie A Marusich; Richard C Kevin; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-03-16       Impact factor: 4.030

9.  In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018.

Authors:  Thomas F Gamage; Daniel G Barrus; Richard C Kevin; David B Finlay; Timothy W Lefever; Purvi R Patel; Megan A Grabenauer; Michelle Glass; Iain S McGregor; Jenny L Wiley; Brian F Thomas
Journal:  Pharmacol Biochem Behav       Date:  2020-04-02       Impact factor: 3.533

10.  Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.

Authors:  Torbjörn U C Järbe; Chen Li; Subramanian K Vadivel; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.